Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATH: Ticagrelor vs Clopidogrel on Myocardial Blood Flow in CAD
NCT01894789Phase 3Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Mar 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in coronary artery disease (CAD), sponsored by University of Ottawa Heart Institute. Started Mar 2013; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01894789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01894789.